HomeTrust Bancshares, Inc. Stock Compensation Disclosure
| Year Ended December 31, | Six Months Ended December 31, 2023 | Year Ended June 30, 2023 | |||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Share-based compensation expense | $ | 2,173 | $ | 1,816 | $ | 755 | $ | 1,854 | |||||||||||||||
| Tax benefit | 511 | 427 | 177 | 436 | |||||||||||||||||||
| Options | Weighted- Average Exercise Price | Remaining Contractual Life (Years) | Aggregate Intrinsic Value | ||||||||||||||||||||
| Options outstanding at June 30, 2023 | 569,224 | $ | 25.69 | 5.1 | $ | 141 | |||||||||||||||||
| Exercised | (9,500) | 15.96 | |||||||||||||||||||||
| Forfeited | (25,374) | 26.00 | |||||||||||||||||||||
| Options outstanding at December 31, 2023 | 534,350 | $ | 25.85 | 4.6 | $ | 776 | |||||||||||||||||
| Exercisable at December 31, 2023 | 459,390 | $ | 25.56 | 4.2 | $ | 681 | |||||||||||||||||
| Non-vested at December 31, 2023 | 74,960 | $ | 27.58 | 7.4 | $ | 95 | |||||||||||||||||
| Options outstanding at December 31, 2023 | 534,350 | $ | 25.85 | 4.6 | $ | 776 | |||||||||||||||||
| Exercised | (97,113) | 25.09 | |||||||||||||||||||||
| Forfeited | (23,600) | 25.94 | |||||||||||||||||||||
| Options outstanding at December 31, 2024 | 413,637 | $ | 26.02 | 3.8 | $ | 3,169 | |||||||||||||||||
| Exercisable at December 31, 2024 | 364,667 | $ | 25.78 | 3.4 | $ | 2,880 | |||||||||||||||||
| Non-vested at December 31, 2024 | 48,970 | $ | 27.77 | 6.7 | $ | 289 | |||||||||||||||||
| Options outstanding at December 31, 2024 | 413,637 | $ | 26.02 | 3.8 | $ | 3,169 | |||||||||||||||||
| Exercised | (57,440) | 24.97 | |||||||||||||||||||||
| Forfeited | (1,400) | 26.72 | |||||||||||||||||||||
| Options outstanding at December 31, 2025 | 354,797 | $ | 26.19 | 2.8 | $ | 5,945 | |||||||||||||||||
| Exercisable at December 31, 2025 | 329,417 | $ | 26.02 | 2.5 | $ | 5,575 | |||||||||||||||||
| Non-vested at December 31, 2025 | 25,380 | $ | 28.37 | 5.9 | $ | 370 | |||||||||||||||||
Restricted Stock Awards(1) | Performance-Based Restricted Stock Units(2) | Weighted- Average Grant Date Fair Value | Aggregate Intrinsic Value | ||||||||||||||||||||
| Non-vested at June 30, 2023 | 108,851 | 37,330 | $ | 27.32 | 1 | $ | 3,054 | ||||||||||||||||
| Granted | 1,000 | 6,165 | 22.91 | — | |||||||||||||||||||
| Vested | (1,148) | (18,494) | 23.18 | — | |||||||||||||||||||
| Forfeited | (2,560) | — | 27.53 | — | |||||||||||||||||||
| Non-vested at December 31, 2023 | 106,143 | 25,001 | $ | 27.70 | $ | 3,530 | |||||||||||||||||
| Granted | 73,502 | 17,690 | 26.96 | — | |||||||||||||||||||
| Vested | (36,639) | (10,683) | 28.26 | — | |||||||||||||||||||
| Forfeited | (4,424) | (2,007) | 27.37 | — | |||||||||||||||||||
| Non-vested at December 31, 2024 | 138,582 | 30,001 | $ | 27.15 | $ | 5,678 | |||||||||||||||||
| Granted | 60,329 | 15,444 | 37.40 | — | |||||||||||||||||||
| Vested | (50,326) | (9,996) | 27.24 | — | |||||||||||||||||||
| Forfeited | (3,621) | (4,108) | 27.19 | — | |||||||||||||||||||
| Non-vested at December 31, 2025 | 144,964 | 31,341 | $ | 31.52 | $ | 7,571 | |||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 13, 2026 | Showing above |
| 2024 | Mar 13, 2025 | |
| 2023 | Sep 11, 2023 | |
| 2022 | Sep 12, 2022 | |
| 2021 | Sep 10, 2021 | |
| 2020 | Sep 11, 2020 | |
| 2019 | Sep 13, 2019 | |
| 2018 | Sep 13, 2018 | |
| 2017 | Sep 12, 2017 | |
| 2016 | Sep 13, 2016 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.